Global Excipients Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Origin;
Organic and InorganicBy Route of Administration;
Oral Excipients, Topical Excipients, Parenteral Excipients, and OthersBy Product;
Polymers, Alcohols, Sugars, Minerals, and GelatinBy Dosage Form;
Solid, Semi-Solid, and LiquidBy Function;
Binders and Coating AgentsBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Introduction
Global Excipients Market (USD Million), 2021 - 2031
Excipients Market was valued at USD 6,590.55 million in the year 2024. The size of this market is expected to increase to USD 9,922.84 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.
Global Excipients Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 6.0 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 6.0 % |
Market Size (2024) | USD 6,590.55 Million |
Market Size (2031) | USD 9,922.84 Million |
Market Concentration | Medium |
Report Pages | 372 |
Major Players
- Eastman Chemical Corporation
- P&G Chemicals
- Avantor Performance Materials, LLC
- Huntsman Corporation
- BASF SE
- Ashland Inc.
- FMC Corporation
- Roquette
- Colorcon Inc.
- Lubrizol Corporation
- Valeant
- JRS Pharma
- Shin-Etsu Chemical Co., Ltd.
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Excipients Market
Fragmented - Highly competitive market without dominant players
The Excipients Market is witnessing consistent growth driven by the expanding pharmaceutical and nutraceutical industries. Excipients play a crucial role in drug formulation by enhancing stability, bioavailability, and patient compliance. With the rise in complex drug formulations and the need for improved drug delivery systems, the demand for advanced excipient solutions has surged by over 20% in recent years. Innovation in excipient technologies is enabling better control over drug release and absorption profiles.
The market is significantly influenced by the increasing use of oral solid dosage forms, which account for over 30% of total excipient consumption. Additionally, rising interest in biopharmaceuticals has propelled the demand for specialized excipients tailored for biologics. The growing preference for clean-label and multifunctional excipients has also driven innovation across formulation technologies. These shifts reflect a broader trend toward formulation efficiency and patient-centric product development.
There is a strong emphasis on developing functional excipients with enhanced properties such as improved solubility, stability, and drug delivery performance. Innovations in co-processed excipients and nanotechnology-based excipients have seen a rise of 18% in adoption. This is largely fueled by the need for formulations that accommodate poorly soluble APIs. Manufacturers are investing in R&D to improve compatibility and reduce the number of inactive ingredients in formulations.
Regulatory and Quality Compliance
Increasing regulatory scrutiny and the push for standardized quality have intensified the focus on excipient safety and functionality. The adoption of Good Manufacturing Practices (GMP) for excipients has risen by 25%, promoting consistency and reducing variability in pharmaceutical formulations. Stringent documentation and traceability requirements have further encouraged collaborations between excipient manufacturers and drug developers.
Future Outlook
The excipients market is expected to benefit from the ongoing expansion of personalized medicine and the rise of orally disintegrating tablets, pediatric, and geriatric-friendly formulations. Over 22% of companies are investing in research to develop novel excipients compatible with advanced drug delivery platforms. With the increasing pace of drug innovation, the excipients market is positioned for strong momentum, supported by material science advancements and strategic formulation partnerships.
Global Excipients Market Recent Developments
-
In June 2023, Ashland introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant comprising a glidant and lubricant.
-
In October 2023, Lubrizol Life Science Health was awarded the Finished Formulation Award for Apisolex Polymer solubilizing excipient at CPhI Barcelona.
Segment Analysis
In this report, the Global Excipients Market has been segmented by Origin, Route of Administration, Product, Dosage Form, Function and Geography.
Global Excipients Market, Segmentation by Origin
The Global Excipients Market has been segmented by Origin into Organic and Inorganic.
Organic
Organic excipients lead the global market with a dominant 73% share, thanks to their widespread use in tablet and capsule formulations. Derived from natural or synthetic organic sources, these materials—including cellulose derivatives, sugars, and polymers—play vital roles as binders, disintegrants, and controlled-release agents. As demand for patient-centric dosage forms and oral delivery innovations grows, organic excipients continue to drive the future of pharmaceutical formulation.
Inorganic
Inorganic excipients, with a 27% share, are favored for their chemical stability, low reactivity, and use in injectables, topicals, and specialty drug formulations. These excipients—such as calcium phosphates, magnesium stearate, and silicon dioxide—are especially useful as fillers, colorants, and buffers, contributing to formulation consistency and drug shelf-life extension.
Global Excipients Market, Segmentation by Route of Administration
The Global Excipients Market has been segmented by Route of Administration into Oral Excipients, Topical Excipients, Parenteral Excipients, and Others.
Oral Excipients
Oral excipients, leading with a 54% share, are essential for the formulation of solid and liquid oral dosage forms. Common examples include microcrystalline cellulose, lactose, and hydroxypropyl methylcellulose (HPMC), which enhance drug delivery efficiency, palatability, and release profiles. Their dominance reflects the global preference for oral medications due to ease of administration and cost-effectiveness.
Topical Excipients
Topical excipients, contributing 19%, are used in formulations applied to the skin or mucosa. These ingredients support drug permeation, hydration, and cosmetic appeal, making them key in dermatological and transdermal therapies. The growing demand for non-invasive drug delivery is fueling expansion in this segment.
Parenteral Excipients
Parenteral excipients, with a 17% market share, are crucial for injectable drug formulations. These components ensure drug solubility, stability, and sterility, making them indispensable in the production of biologics, vaccines, and critical care injectables.
Others
Other excipients, comprising 10%, support alternative drug delivery systems such as inhalers, eye drops, and rectal suppositories. As interest in targeted and site-specific therapies grows, demand for specialized excipients in these niche areas is steadily increasing.
Global Excipients Market, Segmentation by Product
The Global Excipients Market has been segmented by Product into Polymers, Alcohols, Sugars, Minerals and Gelatin.
Polymers
Polymers lead the excipients market with a 41% share, valued for their multifunctional use as binders, controlled-release agents, and stabilizers. Popular types like HPMC, PEG, and PVP are central to both solid oral and injectable formulations. Their adaptability in drug delivery systems supports innovation in extended-release tablets, films, and gels.
Alcohols
Alcohol-based excipients, comprising 22% of the market, are widely used as solubilizers and preservatives in oral, injectable, and topical medications. Ethanol and benzyl alcohol improve drug solubility, extend shelf life, and ensure microbial protection, especially in multi-dose vials and liquid preparations.
Sugars
Sugars, with a 17% market share, enhance taste, texture, and compressibility in pharmaceutical formulations. Commonly used in chewables and liquid syrups, sugars like sorbitol and mannitol are preferred for their palatability and patient-friendly profile.
Minerals
Mineral excipients, contributing 13%, act as functional additives in tablet manufacturing. With roles as lubricants, glidants, and diluents, they support tablet consistency, uniform weight, and improved machinability, making them essential in high-volume production.
Gelatin
Gelatin, making up 7%, is the cornerstone of capsule production due to its gelling and film-forming properties. Used in both pharmaceuticals and nutraceuticals, gelatin supports the encapsulation of both liquids and powders, offering a versatile platform for oral drug delivery.
Global Excipients Market, Segmentation by Dosage Form
The Global Excipients Market has been segmented by Dosage Form into Solid, Semi-Solid, and Liquid.
Solid
Solid dosage forms lead the global excipients market with a 56% share, due to their dominance in tablet and capsule manufacturing. Excipients in this category—such as microcrystalline cellulose, starches, and magnesium stearate—enhance compression, disintegration, and drug release timing. The segment benefits from longer shelf life, mass production scalability, and high patient compliance.
Semi-Solid
Semi-solid forms, accounting for 24%, are critical for topical drug delivery. Excipients in this category help improve spreadability, skin absorption, and product aesthetics. With increasing consumer interest in dermatological and transdermal treatments, demand for excipients in this space is steadily rising.
Liquid
Liquid dosage forms, with a 20% market share, are essential for injections, syrups, and ophthalmic products. Excipients like glycerin, sorbitol, and benzalkonium chloride aid in solubility, preservation, and flavor enhancement. Liquids are preferred in pediatrics, geriatrics, and patients with swallowing difficulties, contributing to their continued growth.
Global Excipients Market, Segmentation by Function
The Global Excipients Market has been segmented by Function into Binders and Coating Agents.
Binders
Binders, which make up 62% of the function-based excipients market, play a crucial role in tablet formulation by ensuring ingredient cohesion and improving tablet hardness. Frequently used binders include HPMC, PVP, and pregelatinized starch, which support uniform drug dispersion and reduce tablet breakage during handling and packaging. As demand grows for high-quality oral solid dosages, binders remain indispensable in pharmaceutical production.
Coating Agents
Coating agents, with a 38% share, are key to enhancing tablet stability, appearance, and drug delivery performance. Whether used for enteric protection, sustained release, or taste masking, coatings improve both formulation performance and patient compliance. Advanced polymer-based coating systems also support targeted drug delivery and branding differentiation.
Global Excipients Market, Segmentation by Geography
In this report, the Global Excipients Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Global Excipients Market Share (%), by Geographical Region, 2024
North America
North America, with a 37% share, is the top contributor to the global excipients market. The region’s leadership stems from its high-volume drug production, strong focus on compliance, and rapid adoption of advanced formulation technologies. Major pharmaceutical companies and CDMOs continue to boost demand for high-quality functional excipients.
Europe
Europe, contributing 29%, is known for its stringent quality standards, mature pharmaceutical ecosystem, and significant investments in orally disintegrating tablets, controlled-release systems, and complex generics. The region benefits from a strong regulatory foundation under EMA guidelines.
Asia Pacific
Asia Pacific, with a 24% market share, is the fastest-growing region thanks to expanding generic drug manufacturing, cost-effective API production, and government support for domestic pharma industries. Countries like India and China are becoming key excipient exporters as well.
Middle East & Africa
Middle East & Africa, with a 5% share, is showing promise with rising formulation outsourcing, increasing domestic production, and growing demand for affordable therapies. Challenges such as regulatory inconsistency and supply chain limitations continue to impact full-scale growth.
Latin America
Latin America, also at 5%, is gaining traction due to public health expansion, growth in local generics, and improved regulatory frameworks. Markets such as Brazil and Mexico are experiencing rising demand for oral and liquid drug formulations, driving excipient needs.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Excipients Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunities Analysis
Drivers:
- Increasing Pharmaceutical Manufacturing
- Advancements in Drug Delivery Technologies
-
Growing Biopharmaceutical Sector - The expansion of the biopharmaceutical sector is significantly influencing the global excipients market. As biologics and biosimilars gain prominence in treating complex conditions, they demand advanced formulation support. This has elevated the role of specialized and multifunctional excipients that enhance drug stability, solubility, and delivery efficiency.
Unlike conventional drugs, biopharmaceuticals require high-purity excipients with greater functional compatibility. In response, manufacturers are developing tailored solutions to support the stringent demands of biologics. Increasing R&D investments across pharmaceutical and contract manufacturing sectors are further driving innovation in this space.
The surge in global clinical trials and approvals of biologic therapies is contributing to consistent excipient demand. These complex drugs need ingredients that meet rigorous quality and regulatory benchmarks, offering opportunities for excipient customization and value addition. As biopharmaceutical pipelines expand globally, the excipients market benefits from a growing reliance on advanced formulation aids that support complex, high-value therapeutics.
Restraints:
- Limited Availability of Raw Materials
- Quality Inconsistencies In Low-Cost Raw Materials
-
Supply Chain Disruptions In Raw Chemical Inputs - A major constraint for the excipients market lies in the disruptions affecting raw material supply chains. Many essential chemicals and intermediates used in excipient production are concentrated among a few global suppliers, making the industry vulnerable to geopolitical events, trade barriers, and logistics breakdowns. This limited sourcing diversity contributes to price volatility and delivery delays, disrupting production timelines and elevating manufacturing costs. Pharmaceutical companies relying on just-in-time inventory strategies face amplified risks due to unpredictable input availability.
Strict regulatory requirements around excipient traceability and purity mean that any compromise in raw chemical quality can lead to compliance failures, product recalls, or delayed approvals. Maintaining consistent quality is essential for global market access. While efforts are being made to diversify suppliers and regionalize production, achieving a fully resilient supply chain remains challenging, keeping this a persistent restraint in excipient manufacturing.
Opportunities:
- Growing Pharmaceutical Industry
- Rising Demand for Oral Solid Dosage Forms
-
Advancements in Drug Delivery Technologies - Evolving drug delivery technologies are opening strong growth avenues for the excipients market. Innovations such as controlled-release systems, nanoparticle formulations, and transdermal patches rely on excipients to improve bioavailability, stability, and patient adherence. The shift toward more targeted and long-acting therapies demands excipients that support optimized release profiles and enhanced therapeutic performance. Co-processed polymers, lipids, and advanced carriers are being designed to meet these evolving needs.
Consumer demand for easy-to-use formats like orally disintegrating tablets and sublingual films has led to increased reliance on excipients that ensure fast dissolution, improved taste masking, and physical integrity of dosage forms. Collaboration between excipient suppliers and drug developers in early-stage formulation is growing, encouraging innovation and accelerating adoption of advanced excipient technologies across a wide range of therapeutic categories.
Competitive Landscape Analysis
Key players in Global Excipients Market include:
- Eastman Chemical Corporation
- P&G Chemicals
- Avantor Performance Materials, LLC
- Huntsman Corporation
- BASF SE
- Ashland Inc.
- FMC Corporation
- Roquette
- Colorcon Inc.
- Lubrizol Corporation
- Valeant
- JRS Pharma
- Shin-Etsu Chemical Co., Ltd.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Origin
- Market Snapshot, By Route of Administration
- Market Snapshot, By Product
- Market Snapshot, By Dosage Form
- Market Snapshot, By Function
- Market Snapshot, By Region
- Global Excipients Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Pharmaceutical Manufacturing
-
Advancements in Drug Delivery Technologies
-
Growing Biopharmaceutical Sector
-
- Restraints
-
Limited Availability of Raw Materials
-
Quality Inconsistencies In Low-Cost Raw Materials
-
Supply Chain Disruptions In Raw Chemical Inputs
-
- Opportunities
-
Growing Pharmaceutical Industry
-
Rising Demand for Oral Solid Dosage Forms
-
Advancements in Drug Delivery Technologies
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Excipients Market, By Origin, 2021 - 2031 (USD Million)
- Organic
- Inorganic
- Global Excipients Market, By Route of Administration, 2021 - 2031 (USD Million)
- Oral Excipients
- Topical Excipients
- Parenteral Excipients
- Others
- Global Excipients Market, By Product, 2021 - 2031 (USD Million)
-
Polymers
-
Alcohols
-
Sugars
-
Minerals
-
Gelatin
-
- Global Excipients Market, By Dosage Form, 2021 - 2031 (USD Million)
- Solid
- Semi-Solid
- Liquid.
- Global Excipients Market, By Function, 2021 - 2031 (USD Million)
-
Binders
-
Coating Agents
-
- Global Excipients Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Excipients Market, By Origin, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Eastman Chemical Corporation
- P&G Chemicals
- Avantor Performance Materials, LLC
- Huntsman Corporation
- BASF SE
- Ashland Inc.
- FMC Corporation
- Roquette
- Colorcon Inc.
- Lubrizol Corporation
- Valeant
- JRS Pharma
- Shin-Etsu Chemical Co., Ltd.
- Company Profiles
- Analyst Views
- Future Outlook of the Market